Apr 14, 2016
The 400 m2 laboratory will be led by Professor Guoping SHI of Harvard Medical School and focus on applications of regulatory T cell technology, e. g., for the treatment of lupus, organ transplantation and cancer. China Bio news release, April 14, 2016
Apr 14, 2016
The objective of this cooperation is to build a cloud-based platform for the development of a nation-wide genome-based personalized medicine („precision medicine“). China Bio news release, April 14, 2016
Apr 14, 2016
A study at Guangzhou Medical University which used human embryos to make them resistant to HIV infection using CRISPR/CAS genome editing tools has led to discussions in China about strengthened legal supervision of such expeeriments. While the Guangzhou work was in...
Apr 14, 2016
According to a statement on April 13, the ministry has established a routine monitoring system aimed at the discovery of illicit cultivation of transgenic vegetables. Three cases concerning transgenic corn seed were discovered in Xinjiang, Gansu and Hainan, the plants...
Apr 12, 2016
The consortium comprises leading antibiotic produceers such as the Tonglian Group and Shenyang’s Chinese Academy of Technology. TIB’s HTS screening platform will be used to arrive at higher yields of the antibiotic of which China is already a major producer CAS news...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
